<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05083338</url>
  </required_header>
  <id_info>
    <org_study_id>2021-0027</org_study_id>
    <secondary_id>NCI-2021-09684</secondary_id>
    <secondary_id>2021-0027</secondary_id>
    <nct_id>NCT05083338</nct_id>
  </id_info>
  <brief_title>Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy</brief_title>
  <official_title>Prospective Evaluation of Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy in Adult Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study learns if depression, anxiety, and catastrophizing (thought patterns that prompt&#xD;
      people to expect the worst) are associated with chronic pain after surgery among patients who&#xD;
      are scheduled to have cytoreductive surgery with intraoperative hyperthermic chemotherapy.&#xD;
      Information from this study may improve the understanding of persistent and chronic&#xD;
      postsurgical pain integrating multiple layers of biological and behavioral sciences.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. To evaluate the association of preoperative psychological risk factors (depression,&#xD;
      anxiety or catastrophizing) with the development of chronic postsurgical pain after&#xD;
      cytoreductive surgery with intraoperative hyperthermic chemotherapy (CRS-HIPEC).&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. To evaluate the association of preoperative psychological risk factors (depression,&#xD;
      anxiety or catastrophizing) with the development of persistent postsurgical pain after&#xD;
      CRS-HIPEC.&#xD;
&#xD;
      II. To evaluate the association between preoperative abnormal sensory disturbances and&#xD;
      chronic postsurgical pain after CRS-HIPEC.&#xD;
&#xD;
      III. To assess the association of blood micro ribonucleic acids (RNAs) signatures with the&#xD;
      development of chronic postsurgical pain after CRS-HIPEC.&#xD;
&#xD;
      IV. To determine the rate of and factors associated with persistent and chronic opioid use&#xD;
      after CRS-HIPEC.&#xD;
&#xD;
      V. To determine the rate of persistent and chronic postsurgical anxiety and depression.&#xD;
&#xD;
      VI. To investigate changes in psychological risk factors (depression, anxiety or&#xD;
      catastrophizing) and sensory disturbances after CRS-HIPEC overtime.&#xD;
&#xD;
      EXPLORATORY OBJECTIVE:&#xD;
&#xD;
      I. To explore the impact of perioperative (in-patient) opioid use, non-opioid analgesic use&#xD;
      and anesthetics on the development of persistent and chronic opioid use after CRS-HIPEC.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients complete questionnaires over 15 minutes and undergo pain assessments prior to&#xD;
      surgery and at 3, 6 and 12 months after surgery. Patients also undergo blood sample&#xD;
      collection before surgery and optionally at 3, 6 and 12 months after surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 10, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Chronic postsurgical pain</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Defined as pain that develops or increases in intensity compared to preoperative after cyotreductive surgery with intraoperative hyperthermic chemotherapy (CRS-HIPEC), lasts for more than 6 months.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">145</enrollment>
  <condition>Appendix Carcinoma</condition>
  <condition>Carcinomatosis</condition>
  <condition>Colorectal Carcinoma</condition>
  <condition>Gastric Carcinoma</condition>
  <condition>Malignant Peritoneal Neoplasm</condition>
  <condition>Malignant Solid Neoplasm</condition>
  <arm_group>
    <arm_group_label>Observational (questionnaire, pain assessment, biospecimen)</arm_group_label>
    <description>Patients complete questionnaires over 15 minutes and undergo pain assessments prior to surgery and at 3, 6 and 12 months after surgery. Patients also undergo blood sample collection before surgery and optionally at 3, 6 and 12 months after surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biospecimen Collection</intervention_name>
    <description>Undergo blood sample collection</description>
    <arm_group_label>Observational (questionnaire, pain assessment, biospecimen)</arm_group_label>
    <other_name>Biological Sample Collection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pain Assessment</intervention_name>
    <description>Undergo pain assessment</description>
    <arm_group_label>Observational (questionnaire, pain assessment, biospecimen)</arm_group_label>
    <other_name>Pain Measurement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Complete questionnaires</description>
    <arm_group_label>Observational (questionnaire, pain assessment, biospecimen)</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with or without history of preoperative abdominal pain&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older; with or without history of preoperative abdominal pain&#xD;
&#xD;
          -  American Society of Anesthesiologists physical status (ASA) 1-4&#xD;
&#xD;
          -  Scheduled surgery: open CRS-HIPEC surgery for primary peritoneal malignancy or&#xD;
             secondary carcinomatosis (i.e., appendiceal, colorectal and gastric cancers)&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA &gt;= 4 or emergency surgeries&#xD;
&#xD;
          -  Patients with extra-abdominal metastatic disease&#xD;
&#xD;
          -  Patients cognitive or neurologically unable to complete questionnaires preoperatively&#xD;
&#xD;
          -  Non-English-speaking patients&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan P Cata</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juan Cata</last_name>
    <phone>(713) 792-7452</phone>
    <email>jcata@mdanderson.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan P. Cata</last_name>
      <phone>713-582-6452</phone>
      <email>jcata@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Juan P. Cata</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>M D Anderson Cancer Center website</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 7, 2021</study_first_submitted>
  <study_first_submitted_qc>October 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Peritoneal Neoplasms</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

